STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$16.87
-0.07 (-0.41%)
▼
5d:
+1.44%
30d:
-5.49%
90d:
+13.99%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.52
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$19.57
13.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $16.87, which is considered oversold relative to its 30-day fair value range of $17.11 to $18.47. The stock's valuation (Forward PE: 20.2) is in line with its historical norms (22.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.9% over the next few years. This pessimistic expectation contrasts with the company's recent 2.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $16.27, while resistance sits at $18.80.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.45 (+44.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $16.27, while resistance sits at $18.80.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.45 (+44.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.11 -
$18.47
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.3% below Wall St target ($24.45)
Trading Range Analysis
30-Day Trading Range
$17.11 -
$18.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.27
Resistance Level
$18.80
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.21
Wall Street Target
$24.45
(+44.3%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
2.9%
Profit Margin
11.8%
Valuation Discount vs History
-2.9% cheaper
PE vs Historical
20.2 vs 22.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.9%
(market-implied from PE analysis)
1-Year Target
$16.45
(-3%)
2-Year Target
$15.97
(-6%)
3-Year Target
$15.51
(-9%)
3-Yr Target (if PE normalizes)
(PE: 20→22)
$16.88
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 18.9%)
$30.70
(+81%)
Base:
(SPY PE: 20.2, Growth: 18.9%)
$28.50
(+68%)
Bear:
(PE: 17.2, Growth: 18.9%)
$24.22
(+43%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 29.73 | Current EPS (TTM): $0.59
Bull Case
$27.40
(+62%)
Analyst growth 42.0%, PE expands to 32.7
Base Case
$24.91
(+47%)
Market implied 42.0%, PE stable at 29.7
Bear Case
$11.93
(-30%)
Severe decline -20.0%, PE contracts to 25.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.2 to 22.0
Stabilization Target:
$18.44
(+8.8%)
PE Expansion Potential:
+8.8%
Share & Embed Analysis
Last updated: June 23, 2026 3:36 PM ET
Data refreshes hourly during market hours. Next update: 4:36 PM
Data refreshes hourly during market hours. Next update: 4:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 50 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 65 BUY |
